ClearArc Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $280K | Sell |
745
-345
| -32% | -$130K | 0.11% | 221 |
|
|
2019
Q3 | $302K | Buy |
1,090
+23
| +2% | +$6.37K | 0.09% | 262 |
|
|
2019
Q2 | $334K | Sell |
1,067
-123
| -10% | -$38.5K | 0.1% | 238 |
|
|
2019
Q1 | $489K | Sell |
1,190
-142
| -11% | -$58.4K | 0.13% | 184 |
|
|
2018
Q4 | $498K | Sell |
1,332
-653
| -33% | -$244K | 0.15% | 167 |
|
|
2018
Q3 | $802K | Sell |
1,985
-6
| -0.3% | -$2.42K | 0.11% | 192 |
|
|
2018
Q2 | $687K | Buy |
1,991
+16
| +0.8% | +$5.52K | 0.1% | 207 |
|
|
2018
Q1 | $680K | Buy |
1,975
+14
| +0.7% | +$4.82K | 0.1% | 208 |
|
|
2017
Q4 | $737K | Sell |
1,961
-18
| -0.9% | -$6.77K | 0.1% | 203 |
|
|
2017
Q3 | $885K | Buy |
1,979
+91
| +5% | +$40.7K | 0.13% | 166 |
|
|
2017
Q2 | $927K | Buy |
1,888
+38
| +2% | +$18.7K | 0.15% | 156 |
|
|
2017
Q1 | $717K | Buy |
1,850
+5
| +0.3% | +$1.94K | 0.12% | 185 |
|
|
2016
Q4 | $677K | Sell |
1,845
-19
| -1% | -$6.97K | 0.12% | 183 |
|
|
2016
Q3 | $749K | Sell |
1,864
-18
| -1% | -$7.23K | 0.14% | 168 |
|
|
2016
Q2 | $657K | Sell |
1,882
-27
| -1% | -$9.43K | 0.13% | 179 |
|
|
2016
Q1 | $688K | Buy |
1,909
+26
| +1% | +$9.37K | 0.15% | 168 |
|
|
2015
Q4 | $1.02M | Buy |
1,883
+8
| +0.4% | +$4.34K | 0.21% | 127 |
|
|
2015
Q3 | $872K | Buy |
1,875
+8
| +0.4% | +$3.72K | 0.18% | 155 |
|
|
2015
Q2 | $952K | Buy |
1,867
+262
| +16% | +$134K | 0.17% | 160 |
|
|
2015
Q1 | $725K | Buy |
1,605
+8
| +0.5% | +$3.61K | 0.15% | 180 |
|
|
2014
Q4 | $655K | Buy |
1,597
+84
| +6% | +$34.5K | 0.13% | 191 |
|
|
2014
Q3 | $545K | Sell |
1,513
-96
| -6% | -$34.6K | 0.12% | 201 |
|
|
2014
Q2 | $454K | Buy |
1,609
+54
| +3% | +$15.2K | 0.1% | 224 |
|
|
2014
Q1 | $467K | Sell |
1,555
-87
| -5% | -$26.1K | 0.12% | 216 |
|
|
2013
Q4 | $452K | Buy |
1,642
+45
| +3% | +$12.4K | 0.12% | 207 |
|
|
2013
Q3 | $500K | Sell |
1,597
-712
| -31% | -$223K | 0.14% | 183 |
|
|
2013
Q2 | $519K | Buy |
+2,309
| New | +$519K | 0.14% | 180 |
|